Angiology Division, Heart and Vessel Department, Lausanne University Hospital, University of Lausanne, Switzerland.
Department of Clinical and Experimental Sciences, University Hospital of Brescia, Italy.
Vasa. 2024 Nov;53(6):378-387. doi: 10.1024/0301-1526/a001139. Epub 2024 Jul 24.
The COVID-19 pandemic has led to significant disruptions in chronic disease care and forced people to stay at home. The effects of such issues on outpatients with lower extremity peripheral artery disease (PAD) remain unknown. Single-centre, retrospective-prospective study conducted in a Swiss University Hospital. Patients with PAD were included between May 1 and July 31, 2020, with a follow-up visit at 12 months. Upon both visits, the Leriche-Fontaine PAD stage was recorded, and study participants underwent ankle-brachial index (ABI) calculation to assess limb perfusion. Functional capacities were assessed through the 6-minute walking and treadmill tests. Major adverse cardiovascular (MACE) and limb events (MALE) were recorded. Data collected during the pandemic were compared with the pre-pandemic period (January 1, 2019-April 30, 2020). Overall, 259 patients were included. Mean age was 69 years and male sex was prevalent (69.1%). Odds of experiencing a degradation in PAD stage were lower during the pandemic than before (odds ratio [OR]: 0.43; 95% confidence interval [CI]: 0.21-0.87; p = 0.018). No significant difference was found between periods in terms of ABI trends. Both pain-free walking time at treadmill test (p = 0.003) and maximal pain intensity at 6-minute walking test (p = 0.001) significantly improved during the pandemic. Compared with the pre-pandemic period, during the pandemic patients were hospitalized less frequently (p = 0.028) and were less likely to undergo elective limb revascularization (p<0.001). No significant difference was found between periods in terms of MALE (p = 0.311), whereas non-fatal strokes were less frequently reported during the pandemic (p = 0.043). In a cohort of outpatients with PAD, we found no evidence of clinical deterioration during the pandemic compared with the pre-pandemic period, though rates of adverse events were nonnegligible in both periods. In case of future pandemics, patients with PAD should be encouraged to maintain an active lifestyle while being closely monitored to avoid clinical worsening.
新型冠状病毒肺炎疫情导致慢性病管理严重中断,迫使人们居家。但目前尚不清楚这些问题对下肢外周动脉疾病(PAD)的门诊患者有何影响。这是一项在瑞士大学医院进行的单中心、回顾性前瞻性研究。2020 年 5 月 1 日至 7 月 31 日期间纳入 PAD 患者,随访时间为 12 个月。在两次就诊时,记录 Leriche-Fontaine PAD 分期,并对研究参与者进行踝肱指数(ABI)计算以评估肢体灌注。通过 6 分钟步行和跑步机测试评估功能能力。记录主要不良心血管(MACE)和肢体事件(MALE)。将疫情期间收集的数据与疫情前(2019 年 1 月 1 日至 2020 年 4 月 30 日)进行比较。共纳入 259 例患者。平均年龄为 69 岁,男性居多(69.1%)。与疫情前相比,疫情期间 PAD 分期恶化的可能性较低(比值比 [OR]:0.43;95%置信区间 [CI]:0.21-0.87;p = 0.018)。ABI 趋势在两个时期之间没有显著差异。跑步机试验时无痛行走时间(p = 0.003)和 6 分钟步行试验时最大疼痛强度(p = 0.001)在疫情期间均显著改善。与疫情前相比,疫情期间患者住院频率较低(p = 0.028),选择性肢体血运重建的可能性较低(p<0.001)。两个时期之间 MALE 无显著差异(p = 0.311),但疫情期间非致命性中风的报告较少(p = 0.043)。在 PAD 门诊患者队列中,与疫情前相比,我们未发现疫情期间临床恶化的证据,但两个时期的不良事件发生率均不可忽视。在未来的大流行中,应鼓励 PAD 患者保持积极的生活方式,同时密切监测以避免临床恶化。